Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors to Define Potential Targets of Targeted and/or Immunomodulatory Therapies

NCT03149523 is registered in ClinicalTrials.gov with European Georges Pompidou Hospital as lead sponsor.

NCT NCT03149523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03149523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors to Define Potential Targets of Targeted and/or Immunomodulatory Therapies
Lead sponsor
European Georges Pompidou Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2017
Completion date
April 30, 2019
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma, hepatic carcinoma, kidney adenocarcinoma